454 related articles for article (PubMed ID: 26462858)
1. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
2. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Kübler AC; Haase T; Staff C; Kahle B; Rheinwald M; Mühling J
Lasers Surg Med; 1999; 25(1):60-8. PubMed ID: 10421887
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Volgin VN; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2012 Sep; 44(7):533-40. PubMed ID: 22851213
[TBL] [Abstract][Full Text] [Related]
5. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
de Visscher SA; Dijkstra PU; Tan IB; Roodenburg JL; Witjes MJ
Oral Oncol; 2013 Mar; 49(3):192-210. PubMed ID: 23068024
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study.
Baas P; Saarnak AE; Oppelaar H; Neering H; Stewart FA
Br J Dermatol; 2001 Jul; 145(1):75-8. PubMed ID: 11453910
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
9. Periorbital skin cancers subjected to mTHPC-photodynamic therapy: A prospective study.
Hamdoon Z; Jerjes W; Hopper C
Skin Res Technol; 2020 May; 26(3):338-342. PubMed ID: 31777106
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.
Lui H; Hobbs L; Tope WD; Lee PK; Elmets C; Provost N; Chan A; Neyndorff H; Su XY; Jain H; Hamzavi I; McLean D; Bissonnette R
Arch Dermatol; 2004 Jan; 140(1):26-32. PubMed ID: 14732656
[TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
12. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
Hopper C; Kübler A; Lewis H; Tan IB; Putnam G
Int J Cancer; 2004 Aug; 111(1):138-46. PubMed ID: 15185355
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.
Apalla Z; Sotiriou E; Chovarda E; Lefaki I; Devliotou-Panagiotidou D; Ioannides D
Br J Dermatol; 2010 Jan; 162(1):171-5. PubMed ID: 19863513
[TBL] [Abstract][Full Text] [Related]
15. Non-metastatic cutaneous squamous cell carcinoma treated with photodynamic therapy using intravenous mTHPC.
Jerjes W; Yousif AA; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2019 Dec; 28():172-176. PubMed ID: 31394299
[TBL] [Abstract][Full Text] [Related]
16. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
Lorenz KJ; Maier H
Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1937-44. PubMed ID: 19290535
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
20. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
